-
1
-
-
84984677163
-
Treatment of patients with cirrhosis
-
27557303
-
Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med. 2016;375:767-77.
-
(2016)
N Engl J Med
, vol.375
, pp. 767-777
-
-
Ge, P.S.1
Runyon, B.A.2
-
2
-
-
84995772564
-
Time trends in the health care burden and mortality of acute on chronic liver failure in the United States
-
27696493
-
Allen AM, Kim WR, Moriarty JP, Shah ND, Larson JJ, Kamath PS. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016;64:2165-72.
-
(2016)
Hepatology
, vol.64
, pp. 2165-2172
-
-
Allen, A.M.1
Kim, W.R.2
Moriarty, J.P.3
Shah, N.D.4
Larson, J.J.5
Kamath, P.S.6
-
3
-
-
77951456114
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
-
20432259
-
Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820-32.
-
(2010)
Hepatology
, vol.51
, pp. 1820-1832
-
-
Starley, B.Q.1
Calcagno, C.J.2
Harrison, S.A.3
-
4
-
-
84928209634
-
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
-
25125077
-
Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547-54.
-
(2015)
Hepatology
, vol.61
, pp. 1547-1554
-
-
Ekstedt, M.1
Hagström, H.2
Nasr, P.3
Fredrikson, M.4
Stål, P.5
Kechagias, S.6
-
5
-
-
84862833567
-
Small RNA and transcriptional upregulation
-
21823233 3154074
-
Portnoy V, Huang V, Place RF, Li LC. Small RNA and transcriptional upregulation. WIREs RNA. 2011;2:748-60.
-
(2011)
WIREs RNA
, vol.2
, pp. 748-760
-
-
Portnoy, V.1
Huang, V.2
Place, R.F.3
Li, L.C.4
-
6
-
-
84960111950
-
SaRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription
-
26902284 4783471
-
Portnoy V, Lin SHS, Li KH, Burlingame A, Hu Z-H, Li H, et al. saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription. Cell Res. 2016;26:320-35.
-
(2016)
Cell Res
, vol.26
, pp. 320-335
-
-
Portnoy, V.1
Lin, S.H.S.2
Li, K.H.3
Burlingame, A.4
Hu, Z.H.5
Li, H.6
-
7
-
-
34249892151
-
In vivo transfection of C/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice
-
17539996
-
Mei S, Wang X, Zhang J, Qian J, Ji J. In vivo transfection of C/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice. Hepatol Res. 2007;37:531-9.
-
(2007)
Hepatol Res
, vol.37
, pp. 531-539
-
-
Mei, S.1
Wang, X.2
Zhang, J.3
Qian, J.4
Ji, J.5
-
8
-
-
84862793486
-
C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo
-
22307857
-
Tao L-L, Cheng Y-Y, Ding D, Mei S, Xu J-W, Yu J, et al. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Apoptosis. 2012;17:492-502.
-
(2012)
Apoptosis
, vol.17
, pp. 492-502
-
-
Tao, L.L.1
Cheng, Y.Y.2
Ding, D.3
Mei, S.4
Xu, J.W.5
Yu, J.6
-
9
-
-
84891940175
-
Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments
-
24273171
-
Hong I-H, Lewis K, Iakova P, Jin J, Sullivan E, Jawanmardi N, et al. Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments. J Biol Chem. 2014;289:1106-8.
-
(2014)
J Biol Chem
, vol.289
, pp. 1106-1108
-
-
Hong, I.H.1
Lewis, K.2
Iakova, P.3
Jin, J.4
Sullivan, E.5
Jawanmardi, N.6
-
10
-
-
28544438792
-
CAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma
-
Ee HT, Shing CH, Mirtha L, Esther W, Sathivel P, Aileen W. et al. CAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Cancer Res.2005;65:10330-7.
-
(2005)
Cancer Res.
, vol.65
, pp. 10330-10337
-
-
Ee, H.T.1
Shing, C.H.2
Mirtha, L.3
Esther, W.4
Sathivel, P.5
Aileen, W.6
-
11
-
-
84883746123
-
C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades
-
23816696
-
Shi Y-C, Zhao H, Yin C, Zeng X, Zhang Q, Xu W-P, et al. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades. Dig Liver Dis. 2013;45:844-51.
-
(2013)
Dig Liver Dis
, vol.45
, pp. 844-851
-
-
Shi, Y.C.1
Zhao, H.2
Yin, C.3
Zeng, X.4
Zhang, Q.5
Xu, W.P.6
-
12
-
-
84894856234
-
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo
-
23929703
-
Reebye V, Sætrom P, Mintz PJ, Huang K-W, Swiderski P, Peng L, et al. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology. 2014;59:216-27.
-
(2014)
Hepatology
, vol.59
, pp. 216-227
-
-
Reebye, V.1
Sætrom, P.2
Mintz, P.J.3
Huang, K.W.4
Swiderski, P.5
Peng, L.6
-
13
-
-
85028675354
-
Development and mechanism of small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver cancer
-
Voutila J, Reebye V, Roberts TC, Protopapa P, Andrikakou P, Blakey DC et al. Development and mechanism of small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver cancer. Mol Ther 2017;25:2705-14.
-
(2017)
Mol Ther
, vol.25
, pp. 2705-2714
-
-
Voutila, J.1
Reebye, V.2
Roberts, T.C.3
Protopapa, P.4
Andrikakou, P.5
Blakey, D.C.6
Al, E.7
-
14
-
-
84903821034
-
Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
-
24832107 4077254
-
Rodrigueza WV, Woolliscroft MJ, Ebrahim A-S, Forgey R, McGovren PJ, Endert G, et al. Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide. Cancer Chemother Pharmacol. 2014;74:151-66.
-
(2014)
Cancer Chemother Pharmacol
, vol.74
, pp. 151-166
-
-
Rodrigueza, W.V.1
Woolliscroft, M.J.2
Ebrahim, A.S.3
Forgey, R.4
McGovren, P.J.5
Endert, G.6
-
15
-
-
84894856234
-
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo
-
23929703
-
Reebye V, Sætrom P, Mintz PJ, Huang K-W, Swiderski P, Peng L, et al. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology. 2014;59:216-27.
-
(2014)
Hepatology
, vol.59
, pp. 216-227
-
-
Reebye, V.1
Sætrom, P.2
Mintz, P.J.3
Huang, K.W.4
Swiderski, P.5
Peng, L.6
-
16
-
-
0035300430
-
Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma
-
11306505
-
Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res. 2001;61:3176-81.
-
(2001)
Cancer Res
, vol.61
, pp. 3176-3181
-
-
Xu, L.1
Hui, L.2
Wang, S.3
Gong, J.4
Jin, Y.5
Wang, Y.6
-
17
-
-
0344837364
-
Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: A possible prognostic marker
-
12680236
-
Tomizawa M, Watanabe K, Saisho H, Nakagawara A, Tagawa M. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker. Anticancer Res. 2003;23:351-4.
-
(2003)
Anticancer Res
, vol.23
, pp. 351-354
-
-
Tomizawa, M.1
Watanabe, K.2
Saisho, H.3
Nakagawara, A.4
Tagawa, M.5
-
18
-
-
77955507119
-
C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation
-
20347819
-
Lu G-D, Leung CH-W, Yan B, Tan CM-Y, Low SY, Aung MO, et al. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology. 2010;139:632-43.
-
(2010)
Gastroenterology
, vol.139
, pp. 632-643
-
-
Lu, G.D.1
Leung, C.H.W.2
Yan, B.3
Tan, C.M.Y.4
Low, S.Y.5
Aung, M.O.6
-
19
-
-
34547133494
-
The C/EBP family of transcription factors: A paradigm for interaction between gene expression and proliferation control
-
17658261
-
Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007;17:318-24.
-
(2007)
Trends Cell Biol
, vol.17
, pp. 318-324
-
-
Nerlov, C.1
-
20
-
-
7244221588
-
Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis
-
15292250
-
Inoue Y, Inoue J, Lambert G, Yim SH, Gonzalez FJ. Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. J Biol Chem. 2004;279:44740-8.
-
(2004)
J Biol Chem
, vol.279
, pp. 44740-44748
-
-
Inoue, Y.1
Inoue, J.2
Lambert, G.3
Yim, S.H.4
Gonzalez, F.J.5
-
21
-
-
0030022255
-
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein
-
8640762
-
Watkins PJ, Condreay JP, Huber BE, Jacobs SJ, Adams DJ. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res. 1996;56:1063-7.
-
(1996)
Cancer Res
, vol.56
, pp. 1063-1067
-
-
Watkins, P.J.1
Condreay, J.P.2
Huber, B.E.3
Jacobs, S.J.4
Adams, D.J.5
-
22
-
-
84869219338
-
MiR-34-a microRNA replacement therapy is headed to the clinic
-
22783274 3387671
-
Bader AG. miR-34-a microRNA replacement therapy is headed to the clinic. Front Genet. 2012;3:120.
-
(2012)
Front Genet
, vol.3
, pp. 120
-
-
Bader, A.G.1
|